We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+18.68%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.69B
AUM Growth
+$682M
Cap. Flow
-$395M
Cap. Flow %
-5.9%
Top 10 Hldgs %
54.02%
Holding
678
New
246
Increased
85
Reduced
72
Closed
235

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$85.8M
2
INDV icon
Indivior Pharmaceuticals
INDV
+$59.6M
3
BCAX
Bicara Therapeutics
BCAX
+$45.8M
4
MRUS
Merus
MRUS
+$34.4M
5
VTRS icon
Viatris
VTRS
+$30M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$102M
2
SGRY icon
Surgery Partners
SGRY
+$86.4M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$53.7M
4
IART icon
Integra LifeSciences
IART
+$42.8M
5
BNTX icon
BioNTech
BNTX
+$38.6M

Sector Composition

Rank Sector Weight
1 Healthcare 87.45%
2 Industrials 0.73%
3 Technology 0.55%
4 Financials 0.45%
5 Consumer Discretionary 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BVS icon
201
Bioventus
BVS
$843M
$752K 0.01%
+62,917
New +$544K
SLM icon
202
SLM Corp
SLM
$4.78B
$750K 0.01%
+32,798
New +$707K
AHR icon
203
American Healthcare REIT
AHR
$11.1B
$747K 0.01%
+28,623
New +$558K
HCSG icon
204
Healthcare Services Group
HCSG
$1.58B
$746K 0.01%
+66,786
New +$733K
DAR icon
205
Darling Ingredients
DAR
$9.62B
$746K 0.01%
+20,072
New +$757K
EVTC icon
206
Evertec
EVTC
$1.88B
$744K 0.01%
+21,941
New +$731K
OPCH icon
207
Option Care Health
OPCH
$3.42B
$739K 0.01%
23,613
+12,797
+118% +$393K
YUMC icon
208
Yum China
YUMC
$15.3B
$739K 0.01%
+16,412
New +$546K
PM icon
209
Philip Morris
PM
$305B
$738K 0.01%
+6,082
New +$707K
KMB icon
210
Kimberly-Clark
KMB
$37B
$734K 0.01%
5,157
-2,101
-29% -$298K
TSLA icon
211
Tesla
TSLA
$1.22T
$730K 0.01%
+2,789
New +$636K
USAP
212
DELISTED
Universal Stainless & Alloy
USAP
$725K 0.01%
18,774
-46,286
-71% -$1.65M
SIGI icon
213
Selective Insurance
SIGI
$5.53B
$722K 0.01%
+7,742
New +$699K
RMD icon
214
ResMed
RMD
$29.5B
$716K 0.01%
2,933
-4,643
-61% -$1.04M
TGT icon
215
Target
TGT
$63.7B
$713K 0.01%
+4,577
New +$682K
PLD icon
216
Prologis
PLD
$137B
$709K 0.01%
+5,618
New +$697K
HUBG icon
217
HUB Group
HUBG
$2.93B
$707K 0.01%
15,555
+1,794
+13% +$79.5K
CPAY icon
218
Corpay
CPAY
$24.8B
$707K 0.01%
2,259
+1,220
+117% +$358K
HNST icon
219
The Honest Company
HNST
$423M
$706K 0.01%
197,756
+47,566
+32% +$178K
LECO icon
220
Lincoln Electric
LECO
$14.1B
$704K 0.01%
+3,664
New +$703K
USAC icon
221
USA Compression Partners
USAC
$3.72B
$703K 0.01%
+30,692
New +$698K
OSUR icon
222
OraSure Technologies
OSUR
$273M
$691K 0.01%
161,812
+9,809
+6% +$42.1K
HRZN icon
223
Horizon Technology Finance
HRZN
$294M
$689K 0.01%
+64,708
New +$740K
EL icon
224
Estee Lauder
EL
$30.1B
$689K 0.01%
+6,912
New +$655K
NOC icon
225
Northrop Grumman
NOC
$77.8B
$683K 0.01%
1,294
-1,066
-45% -$522K
7 8
9
10 11

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2024 Portfolio in Review

As of Q3 2024, Deerfield Management held 678 positions worth $6.69B, up 11% from $6.01B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $395M in Q3 2024, closing 235 positions and reducing 72 holdings. Its most notable exit was Gilead Sciences, an estimated $102M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 83% a quarter earlier, followed by Industrials and Technology.

Against the trend, Deerfield Management opened a new position in Indivior Pharmaceuticals worth $49.7M.

  • Deerfield Management's largest Q3 2024 buy was Indivior Pharmaceuticals: 5,092,642 shares worth $49.7M.
  • Deerfield Management added most to Neurocrine Biosciences in Q3 2024, an estimated $85.8M increase.
  • Deerfield Management's biggest Q3 2024 reduction was Surgery Partners, cutting an estimated $86.4M.
  • Deerfield Management fully exited Gilead Sciences in Q3 2024, selling an estimated $102M.
  • Deerfield Management's ten largest holdings make up 54% of its $6.69B portfolio in Q3 2024.
  • Deerfield Management opened 246 new positions and closed 235 in Q3 2024.
  • Deerfield Management's portfolio value rose 11% quarter-over-quarter to $6.69B.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.